CDP-choline modulates matrix metalloproteinases in rat sciatic injury

Journal of Surgical Research

Volumn 200, Issue 2, 2016, Pages 655-663

  Gundogdu, Elif Basaran ^a   Bekar, Ahmet ^a   Turkyilmaz, Mesut ^a   Gumus, Abdullah ^a   Kafa, Ilker Mustafa ^a   Cansev, Mehmet ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Axonal regeneration; CDP choline; Matrix metalloproteinase; Neuroprotection; Sciatic nerve injury; Tissue inhibitors of metalloproteinases

Indexed keywords

CITICOLINE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; SCLEROPROTEIN; SODIUM CHLORIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; BIOLOGICAL MARKER; MMP2 PROTEIN, RAT; MMP9 PROTEIN, RAT; NEUROPROTECTIVE AGENT; TISSUE INHIBITOR OF METALLOPROTEINASE-1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; EXPERIMENTAL SCIATIC NERVE INJURY; MALE; MYELINATION; NERVE TRANSECTION; NERVOUS TISSUE; NEURITE OUTGROWTH; NEUROPROTECTION; NONHUMAN; PERINEURIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION LEVEL; RAT; UPREGULATION; ZYMOGRAPHY; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; EVALUATION STUDY; INJURIES; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; NERVE REGENERATION; PERIPHERAL NERVE INJURIES; PHYSIOLOGY; RANDOMIZATION; SCIATIC NERVE; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; BIOMARKERS; BLOTTING, WESTERN; CYTIDINE DIPHOSPHATE CHOLINE; INJECTIONS, INTRAPERITONEAL; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; PERIPHERAL NERVE INJURIES; RANDOM ALLOCATION; RATS; RATS, WISTAR; SCIATIC NERVE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84982268812     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.10.003     Document Type: Article

References (39)

1. Fawcett, J.W., Keynes, R.J., Peripheral nerve regeneration. Annu Rev Neurosci, 13, 1990, 43.
2. Griffin, J.W., Hoffman, P.N., Degeneration and regeneration in the peripheral nervous system. Dyck, P.J., Thomas, P.K., Griffin, J.W., Low, P.A., Poduslo, J.F., (eds.) Peripheral Neuropathy, 3rd ed., 1993, WB Saunders Company, Philadelphia, 361.
3. Hughes, P.M., Wells, G.M., Clements, J.M., et al. Matrix metalloproteinase expression during experimental autoimmune neuritis. Brain, 121, 1998, 481.
4. Sanes, J.R., Extracellular matrix molecules that influence neural development. Annu Rev Neurosci, 12, 1989, 491.
5. Martini, R., Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J Neurocytol, 23, 1994, 1.
6. Nagase, H., Visse, R., Murphy, G., Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res, 69, 2006, 562.
7. Sternlicht, M.D., Werb, Z., How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol, 17, 2001, 463.
8. Crocker, S.J., Pagenstecher, A., Campbell, I.L., The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res, 75, 2004, 1.
9. Kennedy, E.P., Weiss, S.B., The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem, 222, 1956, 193.
10. Cansev, M., Yilmaz, M.S., Ilcol, Y.O., Hamurtekin, E., Ulus, I.H., Cardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system. Eur J Pharmacol, 577, 2007, 129.
11. Ilcol, Y.O., Cansev, M., Yilmaz, M.S., Hamurtekin, E., Ulus, I.H., Intraperitoneal administration of CDP-choline and its cholinergic and pyrimidinergic metabolites induce hyperglycemia in rats: involvement of the sympathoadrenal system. Arch Physiol Biochem, 113, 2007, 186.
12. Cansev, M., Ilcol, Y.O., Yilmaz, M.S., Hamurtekin, E., Ulus, I.H., Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations. Auton Autacoid Pharmacol, 28, 2008, 41.
13. Ilcol, Y.O., Cansev, M., Yilmaz, M.S., Hamurtekin, E., Ulus, I.H., Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: muscarinic and nicotinic acetylcholine receptors are both involved in their actions. Neurosci Lett, 431, 2008, 71.
14. Cansev, M., Ilcol, Y.O., Yilmaz, M.S., Hamurtekin, E., Ulus, I.H., Choline, CDP-choline or phosphocholine increases plasma glucagon in rats: involvement of the peripheral autonomic nervous system. Eur J Pharmacol, 589, 2008, 315.
15. Adibhatla, R.M., Hatcher, J.F., Cytidine 5’-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem Res, 30, 2005, 15.
16. Cetinkaya, M., Cansev, M., Kafa, I.M., et al. Cytidine 5’-diphosphocholine ameliorates hyperoxic lung injury in a neonatal rat model. Pediatr Res, 74, 2013, 26.
17. Cetinkaya, M., Cansev, M., Cekmez, F., et al. CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis. J Surg Res, 183, 2013, 119.
18. Ozay, R., Bekar, A., Kocaeli, H., Karli, N., Filiz, G., Ulus, İ.H., Citicoline improves functional recovery, promotes nerve regeneration, and reduces postoperative scarring after peripheral nerve surgery in rats. Surg Neurol, 68, 2007, 615.
19. Aslan, E., Kocaeli, H., Bekar, A., Tolunay, S., Ulus, I.H., CDP-choline and its endogenous metabolites, cytidine and choline, promote the nerve regeneration and improve the functional recovery of injured rat sciatic nerves. Neurol Res, 33, 2011, 766.
20. Caner, B., Kafa, M.I., Bekar, A., et al. Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury. Neurol Res, 34, 2012, 238.
21. Kaplan, T., Kafa, I.M., Cansev, M., et al. Investigation of the dose-dependency of citicoline effects on nerve regeneration and functional recovery in a rat model of sciatic nerve injury. Turk Neurosurg, 24, 2014, 54.
22. Petersen, J., Russell, L., Andrus, K., MacKinnon, M., Silver, J., Kliot, M., Reduction of extraneural scarring by ADCON-T/N after surgical intervention. Neurosurgery, 38, 1996, 976.
23. Gorgulu, A., Imer, M., Simsek, O., Sencer, A., Kutlu, K., Cobanoglu, S., The effect of aprotinin on extraneural scarring in peripheral nerve surgery: an experimental study. Acta Neurochir (Wien), 140, 1998, 1303.
24. Gorgulu, A., Uzal, C., Doganay, L., Imer, M., Eliuz, K., Cobanoglu, S., The effect of low-dose extraneural scarring after peripheral nerve surgery in rats. Neurosurgery, 53, 2003, 1389.
25. Shah, M.H., Kasabian, A.K., Karp, N.S., et al. Axonal regeneration through an autogenous nerve bypass: an experimental study in the rat. Ann Plast Surg, 38, 1997, 408.
26. Brown, R.E., Detlev, E., Lyons, S.F., Suchy, H., The use of cultured schwann cells in nerve repair in rabbit hind-limb model. J Reconstr Microsurg, 12, 1996, 149.
27. Tanabe, K., Bonilla, I., Winkles, J.A., Strittmatter, S.M., Fibroblast growth factor-inducible-14 is induced in axotomized neurons and neurite outgrowth. J Neurosci, 23, 2003, 9675.
28. Labrador, R.O., Buti, M., Navarro, X., Influence of collagen and laminin gels concentration on nerve regeneration after resection and tube repair. Exp Neurol, 149, 1998, 243.
29. Lundborg, G., A 25-Year perspective of peripheral nerve surgery: evolding neuroscientific concepts and clinical significance. J Hand Surg Am, 25, 2000, 391.
30. Beris, A.E., Lykissas, M.G., Experimental results in end-to-side neurorraphy. Int Rev Neurobiol, 87, 2009, 269.
31. Zhang, H., Chang, M., Hansen, C.N., Basso, D.M., Noble-Haeusslein, L.J., Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury. Neurotherapeutics, 8, 2011, 206.
32. Kobayashi, H., Chattopadhyay, S., Kato, K., et al. MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage. Mol Cell Neurosci, 39, 2008, 619.
33. Demestre, M., Gregson, A., Smith, K.J., Miller, K.M., Gearing, A.J., Hughes, R.A., Effect of a matrix metalloproteinase inhibitor (BB-1101) on nerve regeneration. Ann N Y Acad Sci, 878, 1999, 658.
34. Siebert, H., Dippel, N., Mader, M., Weber, F., Bruck, W., Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol, 60, 2001, 85.
35. Hughes, P.M., Wells, G.M., Perry, V.H., Brown, M.C., Miller, K.M., Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems. Neuroscience, 113, 2002, 273.
36. Shubayev, V.I., Myers, R.R., Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res, 855, 2000, 83.
37. Fleur, M., Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med, 184, 1996, 2311.
38. Burggraf, D., Trinkl, A., Dichgans, M., Hamann, G.F., Doxycycline inhibits MMPs via modulation of plasminogen activators in focal cerebral ischemia. Neurobiol Dis, 25, 2007, 506.
39. Platt, C.I., Krekoski, C.A., Ward, R.V., Edwards, D.R., Gavrilovic, J., Extracellular matrix and matrix metalloproteinases in sciatic nerve. J Neurosci Res, 74, 2003, 417.